Type 2 diabetes mellitus: Dapagliflozin (FORXIGA) is indicated in adults with type 2 diabetes mellitus for: the treatment of diabetes as an adjunct to diet and exercise. Dapagliflozin (FORXIGA) can be given as monotherapy or in combination with other medicinal products indicated for the treatment of type 2 diabetes mellitus (see Pharmacology: Pharmacodynamics under Actions).
The prevention of new or worsening heart failure or cardiovascular death (see Pharmacology: Pharmacodynamics under Actions).
The prevention of new or worsening nephropathy (see Pharmacology: Pharmacodynamics under Actions).
Heart failure: Dapagliflozin (FORXIGA) is indicated in adults for the treatment of heart failure (see Pharmacology: Pharmacodynamics under Actions).
Chronic kidney disease: Dapagliflozin (FORXIGA) is indicated in adults for the treatment of chronic kidney disease (see Pharmacology: Pharmacodynamics under Actions).
Limitations of Use: Dapagliflozin (FORXIGA) is not indicated for use in patients with type 1 diabetes.
Dapagliflozin (FORXIGA) should not be used for the treatment of diabetic ketoacidosis.
                                
                            Other Services
                            
                            
                            Country
                            Account
                            
                         
 
            
 
         
                 
                                     
                             
                                             
                                             Sign Out
 Sign Out
                                     
                                             
                                             
                                            